Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Adicet Bio Inc shares valued at $8,437 were sold by Kauffman Michael on Jun 05 ’24. At $1.43 per share, Kauffman Michael sold 5,900 shares. The insider’s holdings dropped to 5,900 shares worth approximately $5959.0 following the completion of this transaction.
Analysts at H.C. Wainwright downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid September. As of June 27, 2023, JMP Securities has decreased its “Mkt outperform” rating to a “Mkt perform” for ACET. Earlier on June 27, 2023, Guggenheim downgraded its rating. Their new recommendation was “a Neutral” for ACET stock which previously was a “a Buy”.
Analyzing ACET Stock Performance
During the last five days, there has been a surge of approximately 11.97%. Over the course of the year, Adicet Bio Inc shares have jumped approximately 4.99%. Shares of the company reached a 52-week high of $1.1100 on 01/03/25 and a 52-week low of $0.8500 on 02/03/25. A 50-day SMA is recorded $0.9580, while a 200-day SMA reached $1.3038. Nevertheless, trading volume fell to 21.13 million shares from 0.19 million shares the previous day.
Support And Resistance Levels for Adicet Bio Inc (ACET)
According to the 24-hour chart, there is a support level at 0.8967, which, if violated, would cause prices to drop to 0.7833. In the upper region, resistance lies at 1.0867. The next price resistance is at 1.1633. RSI (Relative Strength Index) is 59.30 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0240, which suggests the price will decrease in the coming days. Percent R is at 20.00%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
